Skip to main content

Table 1 Mortality in tumor-related status epilepticus versus status epilepticus due to another cause

From: Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis

Author

Total no of patients

No of tumor patients

Mortality in tumor group

Mortality in non-tumor group

Mortality in non-tumor group, HAE excluded

Type of study

Setting

Amare [12]

119

13

23.1%

19.8%

18.4%

Retrospective

Tertiary hospital

Cavaliere [13]*

35

34

23.0%

0%

0%

Retrospective

University hospital

Chen [14]**#

220

17

11.8%

15.3%

n/a#

Prospective

University hospital

DeLorenzo [7]

137

10

30.0%

36.2%

31.4%

Prospective

Population based

Li [15]

203

15

13.3%

16.0%

16.1%

Retrospective

University hospital

Rossetti [16]

96

14

21.4%

14.6%

14.6%

Prospective

University hospital

Scholtes [17]

236

12

16.7%

14.7%

14.8%

Retrospective

Hospitals and epilepsy centers

Towne [18]

253

11

36.0%

22.7%

17.5%

Retrospective

Hospital

Wu [19]

15601

291

15.5%

10.7%

5.8%

Retrospective

Population based

Total

16900

417

     

Weighted averages

  

17.2%

11.3%

6.5%

  
  1. *This study only included tumor patients; one patient had a systemic tumor without brain-metastasis. **Brain neoplasm and developmental malformation were in the same group. Separate data could not be obtained. #No separate data on hypoxic/anoxic encephalopathy were given. HAE = hypoxic/anoxic encephalopathy.